İlknur Deliktaş Onur

12PUBLICATIONS
93CO-AUTHORS
Innate immunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMidwifery not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 26, 2026
Prognostic Value of the Inflammatory Burden Index (IBI) in Metastatic Urothelial Carcinoma Prior to First-Line Therapy.

|Jun 25, 2026
Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey.

|Jun 12, 2026
Local Ablative Therapy in Breast Cancer Liver Metastases: Survival Outcomes and Prognostic Factors-A Single-Center Retrospective Study.

|May 04, 2026
Clinicopathological Predictors of Pathological Complete Response in HER2-Positive Breast Cancer Treated with Pertuzumab-Based Neoadjuvant Therapy: A Multicenter Real-World Study.

|Mar 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur

|Nov 26, 2025
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study.

İlknur Deliktaş Onur, Mutlu Doğan, Mehmet Akif Öztürk

Pageof 2

Frequent Collaborators

3 joint publications

Öztürk Ateş

3 joint publications

Ferit Aslan

2 joint publications

Osman Sütcüoğlu

2 joint publications

Elif Sertesen Çamöz